Rates of homologous recombination deficiency across different subtypes of ovarian cancer and in pre- and post-neoadjuvant chemotherapy tumor samples (139.5)-Reference-Cited by-同舟云学术

Rates of homologous recombination deficiency across different subtypes of ovarian cancer and in pre- and post-neoadjuvant chemotherapy tumor samples (139.5)

Published:2022-08 Issue: Volume:166 Page:S86-S87
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Zalaznick Hillary,Clegg Benjamin,Cogan Elizabeth,Perry Michael,Trost Jeffrey,Mancini-DiNardo Debora,Gutin Alexander,Lanchbury Jerry,Timms Kirsten

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for genetic testing in epithelial ovarian cancer in the United Kingdom;International Journal of Gynecologic Cancer;2024-09

2. A retrospective study of Pipelle endometrial biopsy for ovarian, fallopian tube, and peritoneal cancers;Journal of Obstetrics and Gynaecology;2023-11-20

3. A case of ovarian carcinosarcoma with a germline pathogenic variant of BRCA2 involving a perforated appendix with an abscess;Journal of Obstetrics and Gynaecology Research;2023-07-18

4. The landscape of BRCA1 and BRCA2 large rearrangements in an international cohort of over 20 000 ovarian tumors identified using next‐generation sequencing;Genes, Chromosomes and Cancer;2023-05-24

5. Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational study;International Journal of Gynecologic Cancer;2023-04-18